Sign Up to like & get recommendations! 0
Published in 2020 at "Archives of Gynecology and Obstetrics"
DOI: 10.1007/s00404-020-05855-1
Abstract: Purpose Ovarian hyperstimulation syndrome (OHSS) is a life-threatening complication of ovarian stimulation in reproductive medicine. Here, we aimed to investigate the role of oxytocin (OT) and cabergoline in the prevention and alleviation of the OHSS… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Clinical biochemistry"
DOI: 10.1016/j.clinbiochem.2021.05.007
Abstract: OBJECTIVE Our study aims to evaluate the diagnostic performance of a high-sensitivity picoAnti-Müllerian Hormone (picoAMH) for predicting ovarian response in women undergoing controlled ovarian hyperstimulation and occurrence of ovarian hyperstimulation syndrome. METHODS Retrospective cohort study… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Fertility and sterility"
DOI: 10.1016/j.fertnstert.2017.06.017
Abstract: OBJECTIVE To evaluate endocrine characteristics and clinical outcomes in normal ovulatory patients undergoing controlled ovarian hyperstimulation (COH) with the use of a Duphaston and hMG protocol during in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) treatments in… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Reproductive biomedicine online"
DOI: 10.1016/j.rbmo.2016.10.004
Abstract: Triptorelin 0.2 mg and leuprolide 1 mg subcutaneous injections for triggering final follicular maturation were compared in patients with a high risk for ovarian hyperstimulation syndrome (OHSS). Infertile patients treated with GnRH antagonist protocol between January 2014… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Reproductive biology"
DOI: 10.1016/j.repbio.2019.03.005
Abstract: Vascular endothelial growth factor (VEGF) is the most important angiogenic mediator in ovarian hyperstimulation syndrome OHSS. Studies proved that cabergoline administration blocks the increase in vascular permeability via dephosphorylation of VEGF receptors and hence can… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Seminars in reproductive medicine"
DOI: 10.1055/s-0041-1736492
Abstract: Ovarian hyperstimulation syndrome (OHSS) is a severe complication of controlled ovarian stimulation (COS). Pathogenesis of the disease is based on massive transudation of protein-rich fluid from the vascular compartment into the peritoneal, pleural and pericardial… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of Obstetrics and Gynaecology"
DOI: 10.1080/01443615.2017.1346593
Abstract: Abstract This study aimed to evaluate the effect of methylprednisolone on prevention of ovarian hyperstimulation syndrome (OHSS) in polycystic ovarian syndrome (PCOS) patients undergoing in-vitro fertilisation (IVF). This randomised controlled trial was carried out between… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Gynecological Endocrinology"
DOI: 10.1080/09513590.2022.2122429
Abstract: Abstract This article reported a rare case of severe ovarian hyperstimulation syndrome (OHSS) following oral clomiphene. The patient was instructed to take clomiphene on the 5th day of menstruation, 50 mg daily for 5 days, without any… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Gynecological Endocrinology"
DOI: 10.1080/09513590.2022.2163233
Abstract: Abstract Objective: Ovarian hyperstimulation syndrome is an iatrogenic condition that occurs in the treatment of infertility. There is no specific treatment available for OHSS. Cabergoline is a dopamine receptor 2 agonist and VEGF-VEGF2 receptor antagonist… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Genetic testing and molecular biomarkers"
DOI: 10.1089/gtmb.2018.0205
Abstract: AIMS To correlate differences in estradiol levels in serum and follicular fluid with genetic variants and to determine if they play a role in the results following assisted reproductive technology (ART). PATIENTS AND METHODS A… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Critical Care Medicine"
DOI: 10.1097/01.ccm.0000529096.02568.cf
Abstract: Critical Care Medicine • Volume 46 • Number 1 (Supplement) www.ccmjournal.org Learning Objectives: Ovarian hyperstimulation syndrome (OHSS) is one of the rare, iatrogenic reproductive emergencies that is encountered in critical care. Due to an increase… read more here.